No surprise here."The annual cost of prescription diabetes drugs nearly doubled to $12.5 billion between 2001 and 2007, according to a study by researchers at the Stanford University School of Medicine and the University of Chicago. The researchers say the findings raise questions about whether the higher cost actually translates into improved care and better outcomes.
'It's important to recognize how expensive treatment for diabetes has become,' said Randall Stafford, MD, PhD, associate professor of medicine at the Stanford Prevention Research Center and senior author of the study. 'This near-doubling of diabetes costs may partly reflect better care, but we need to step back and examine the value of newer and more costly medications that may be overused.'"
Fitness Watch is your site for making sense of fitness advice.
"Truth" has a shelf life.
The shelf life of "truth" is very short in the domains of fitness, health and well-being.
The reason is that so much of what we are told is "true" is really baseless.
At Fitness Watch we separate fitness information from fitness noise.
Monday, January 12, 2009
Costlier New Diabetes Drugs Don't Necessarily Produce Better Outcomes, Stanford Researcher Says
When Big Pharma meets Big Fatso.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.